Scynexis (SCYX) Amortization of Deferred Charges (2013 - 2025)
Scynexis (SCYX) reported Amortization of Deferred Charges of $312000.0 for Q1 2025, down 22.19% on a YoY basis from $401000.0 in Q1 2024, and down 32.76% quarter-over-quarter from $464000.0 in Q4 2024.
Scynexis (SCYX) Amortization of Deferred Charges (2013 - 2025) Analysis & Trends
Scynexis has reported Amortization of Deferred Charges for 12 years, with the latest figure at $312000.0 in Q1 2025.
- For the quarter ending Q1 2025, Amortization of Deferred Charges fell 22.19% year-over-year to $312000.0; the trailing twelve-month figure through Dec 2025 stood at $312000.0 (down 81.93% YoY), and the FY2025 full-year result was $312000.0, down 81.92% from the prior year.
- Amortization of Deferred Charges for Q1 2025 stood at $312000.0, down from $464000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $2.0 million in Q2 2023, with the low at $255000.0 in Q1 2023.
- Historically, Amortization of Deferred Charges has averaged $466823.5 across 5 years, with a median of $395000.0 in 2022.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges soared 374.58% — and 2024, when it tumbled 78.93%.
- Scynexis' Amortization of Deferred Charges stood at $366000.0 in 2021, then advanced by 7.92% to $395000.0 in 2022, then dropped by 4.3% to $378000.0 in 2023, then gained by 22.75% to $464000.0 in 2024, then tumbled by 32.76% to $312000.0 in 2025.
- The last three Amortization of Deferred Charges figures came in at $312000.0 (Q1 2025), $464000.0 (Q4 2024), and $441000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 312,000.00 |
| Mar 31, 2025 | 312,000.00 |
| Dec 31, 2024 | 464,000.00 |
| Dec 31, 2024 | 464,000.00 |
| Sep 30, 2024 | 441,000.00 |
| Sep 30, 2024 | 441,000.00 |
| Jun 30, 2024 | 421,000.00 |
| Jun 30, 2024 | 421,000.00 |
| Mar 31, 2024 | 401,000.00 |
| Mar 31, 2024 | 401,000.00 |
| Dec 31, 2023 | 378,000.00 |
| Dec 31, 2023 | 378,000.00 |
| Sep 30, 2023 | 360,000.00 |
| Sep 30, 2023 | 360,000.00 |
| Jun 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 255,000.00 |
| Mar 31, 2023 | 255,000.00 |
| Dec 31, 2022 | 395,000.00 |
| Dec 31, 2022 | 395,000.00 |